CDC Reports First-Ever Profound Autism Prevalence Data

The Centers for Disease Control and Prevention today reported 26.7 percent of people with autism spectrum disorder have "profound autism". It is the first ...

April 20, 2023 | Thursday | News
PANTHERx® Rare Announces Release of CUVRIOR™ to Treat Wilson Disease

"We are pleased to add CUVRIOR to the list of PANTHERx® medications. The PANTHERx team works hard to make a positive difference in the lives of ou...

April 20, 2023 | Thursday | News
Scientists Discover Key Role of Glucose in Brain Activity

The human brain has a sweet tooth, burning through nearly one quarter of the body's sugar energy, or glucose, each day. Now, researchers at Gladstone Insti...

April 19, 2023 | Wednesday | News
Cali Biosciences Begins Phase III Study of Long-Acting Ropivacaine for Pain Reduction After Surgery

Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the research and development o...

April 19, 2023 | Wednesday | News
Collaboration to Improve Early Blood Cancer Detection and Treatment

Juntendo University, Sysmex Corporation, and ThinkCyte K.K. have announced a collaborative research partnership to advance the early detection and treatmen...

April 19, 2023 | Wednesday | News
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

"Today's approval is an important advance in cell therapy treatment in patients with blood cancers," said Peter Marks, M.D., Ph.D., director of the FDA's C...

April 18, 2023 | Tuesday | News
Shionogi Shows Fetcroja Efficacy Against Tough Gram-Negative Bacteria in Real-World Evidence

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announces key data for Fetcroja&...

April 18, 2023 | Tuesday | News
Otsuka and Lundbeck's Statement on FDA Advisory Committee Meeting for REXULTI in Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psy...

April 18, 2023 | Tuesday | News
Scientists from Singapore & Sweden makes progress in restoring vision lost to cellular degeneration

 A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplant...

April 17, 2023 | Monday | News
Alpro Pharmacy Increases Order Fulfilment Efficiency by 80% with Zebra Technologies’ Solutions

 Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the front  line of business with solutions and partners that deliver a performanc...

April 17, 2023 | Monday | News
IPS HEART receives FDA Rare Pediatric Drug Designations for both of its Stem Cell Drugs for Duchenne Muscular Dystrophy

The FDA has also recently granted an orphan drug designation (ODD) to GIVI-MPC. Current treatments for DMD have limited therapeutic potential as unfortunat...

April 14, 2023 | Friday | News
Adaptive Biotech, Takeda collaborate to measure disease with clonoSEQ® assay.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sy...

April 14, 2023 | Friday | News
Aspect Biosystems, Novo Nordisk partner to bioprint tissue therapies for diabetes, obesity.

Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation ...

April 14, 2023 | Friday | News
ZyVersa Publishes Review Article on Targeting Microglial Inflammation in Alzheimer's Disease

During aging, the central nervous system (“CNS”) becomes more inflammatory, leading to activation of microglia (“CNS immune cells&rdquo...

April 13, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close